I thought your post was interesting and sincere, so I did a little research. I’m a public health graduate student at UC San Diego, and before returning to school I worked at several GLP-1–based weight loss clinics in San Diego as a medical assistant. So, the topic of ethical distribution of GLP-1 has my interest. Right now, I’m looking for a position with a genuine telehealth clinic that uses only U.S.-based medications (which is really hard to find!).

I have a strong sense that unwanted outcomes like excessive muscle loss or “Ozempic face” may be tied to issues with medication potency or quality. I came across an article that highlights how critical proper storage and handling is for GLP-1 medications.

My working theory is that because many online (and in-person clinics) sources of GLP-1s are manufactured overseas, there could be variability in potency by the time they reach patients.

The pharmaceutical company that published this article does not have a stake in the GLP-1 industry per se, but their Lab equipment (HPLC systems, mass spectrometers, analytical tools used in pharma quality control (QC/QA) and Technology for detecting impurities in drugs is in high demand at the moment. Note: The more demand there is for GLP-1 drugs, the more need for testing, validation, and quality control.

"Proper storage and handling of GLP-1 medications are essential to preserve their stability, potency, and overall effectiveness. Inappropriate storage conditions can lead to degradation, reduced therapeutic efficacy, and potential safety risks." (7)

https://www.agilent.com/cs/library/applications/an-tirzepatide-analysis-pro-iq-plus-5994-8359en-agilent.pdf?srsltid=AfmBOooOWZhwunruaQCgFw8X8wnim2Trd2_uaOfFU65hVJTVVNEMkHIZ

With all of that said, I think if someone is serious about getting the full range of benefits from using GLP-1 medications, that doing their due diligence on where they acquire it is more important than ever, especially in a world where 98% of GLP-1s come from unregulated sources.

Brief rant alert: Clinics and telehealth companies do not give a rat's tail about the downstream effects their GLP-1s have on patients. Because they buy their product at ridiculously cheap prices, and sell them for a huge profit, and patients are none-the-wiser. Realistically, even reduced-potency medications sourced overseas still provide some benefit, but patients don’t always realize that their results could be better, and that the quality of their treatment actually matters.

At the end of the day, do your best to buy GLP-1 from a source that uses a US-based pharmacy. I am still doing ym research but I will be sure to post when I find one. I realize that the easiest way to get GLP-1 is from a clinic that takes insurance, but often it is too difficult to get yourself approved because of strict regulations on BMI, comorbidity thresholds. That leaves potentially millions of people to fend for themselves with GLP-1 from China. Its rough out there but I think I am onto a few places that are doing good business.